Oxidative stress and the development of diabetic retinopathy: Contributory role of matrix metalloproteinase-2

Free Radical Biology and Medicine - Tập 46 - Trang 1677-1685 - 2009
Renu A. Kowluru1, Mamta Kanwar1
1Kresge Eye Institute, Wayne State University, Detroit, MI 48201, USA

Tài liệu tham khảo

Baynes, 1991, Role of oxidative stress in development of complications in diabetes, Diabetes, 40, 405, 10.2337/diabetes.40.4.405

Kowluru, 1991, Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system, Free Radic. Biol. Med., 22, 587, 10.1016/S0891-5849(96)00347-4

Kowluru, 2001, Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy, Diabetes, 50, 1938, 10.2337/diabetes.50.8.1938

Kowluru, 2003, Diabetes-induced mitochondrial dysfunction in the retina, Investig. Ophthalmol. Vis. Sci., 44, 5327, 10.1167/iovs.03-0353

Feldmen, 2003, Oxidative stress and diabetic neuropathy: a new understanding of an old problem, J. Clin. Invest., 111, 431, 10.1172/JCI200317863

Brownlee, 2005, The pathobiology of diabetic complications: a unifying mechanism, Diabetes, 54, 1615, 10.2337/diabetes.54.6.1615

Caldwell, 2005, Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress, Curr. Drug Targets, 6, 511, 10.2174/1389450054021981

Kanwar, 2007, Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase, Investig. Ophthalmol. Vis. Sci., 48, 3805, 10.1167/iovs.06-1280

Kowluru, 2006, Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress, Free Radic. Biol. Med. Sci., 41, 1191, 10.1016/j.freeradbiomed.2006.01.012

Malemud, 2006, Matrix metalloproteinases (MMPs) in health and disease: an overview, Front. Biosci., 11, 1696, 10.2741/1915

Itoh, 2006, CMT1-MMP: a potent modifier of pericellular microenvironment, J. Cell. Physiol., 206, 1, 10.1002/jcp.20431

Liotta, 1996, Probing the depths of degradation: matrix metalloproteinase-2 and endometrial menstrual breakdown, J. Clin. Invest., 97, 273, 10.1172/JCI118412

Pfeilschifter, 2001, Nitric oxide and mechanisms of redox signalling: matrix and matrix-metabolizing enzymes as prime nitric oxide targets, Eur. J. Pharmacol., 429, 279, 10.1016/S0014-2999(01)01326-7

Cox, 2002, Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats, Am. J. Physiol, Heart Circ. Physiol., 282, H1197, 10.1152/ajpheart.00483.2001

Ho, 2007, Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells, J. Cell. Biochem., 101, 442, 10.1002/jcb.21192

Schulz, 2007, Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches, Annu. Rev. Pharmacol. Toxicol., 47, 211, 10.1146/annurev.pharmtox.47.120505.105230

Das, 1999, Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes, Investig. Ophthalmol. Vis. Sci., 40, 809

Jin, 2001, Matrix metalloproteinases in human diabetic and nondiabetic vitreous, Retina, 21, 28, 10.1097/00006982-200102000-00005

Giebel, 2005, Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier, Lab. Invest., 85, 567, 10.1038/labinvest.3700251

Shiau, 2006, Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus, Mt. Sinai J. Med., 73, 1024

Yang, 2007, Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy, Ann. N.Y. Acad. Sci., 1103, 196, 10.1196/annals.1394.000

Navaratna, 2007, Proteolytic degradation of VE-cadherin alters the blood–retinal barrier in diabetes, Diabetes, 56, 2380, 10.2337/db06-1694

Mizutani, 1996, Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy, J. Clin. Invest., 97, 2883, 10.1172/JCI118746

Kern, 2000, Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia, Investig. Ophthalmol. Vis. Sci., 41, 3972

Gardner, 2002, Diabetic retinopathy: more than meets the eye, Surv. Ophthalmol., 47, S253, 10.1016/S0039-6257(02)00387-9

Kowluru, 2004, Effect of long-term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats, Diabetes, 53, 3233, 10.2337/diabetes.53.12.3233

Kowluru, 2008, AREDS-based micronutrients inhibit retinopathy and retinal metabolic abnormalities in diabetic rats, Arch. Ophthalmol., 126, 1266, 10.1001/archopht.126.9.1266

Kowluru, 2007, Small molecular weight G-protein, H-Ras, and retinal endothelial cell apoptosis in diabetes, Mol. Cell. Biochem., 296, 69, 10.1007/s11010-006-9299-z

Zheng, 2004, Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors, Diabetes, 53, 2420, 10.2337/diabetes.53.9.2420

Ikejiri, 2005, Potent mechanism-based inhibitors for matrix metalloproteinases, J. Biol. Chem., 280, 33992, 10.1074/jbc.M504303200

Chen, 2003, Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells, Investig. Ophthalmol. Vis. Sci., 44, 5016, 10.1167/iovs.03-0418

Kanwar, 2008, Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implications in the development of retinopathy, Microvasc. Res., 76, 189, 10.1016/j.mvr.2008.04.002

Romanic, 1998, Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size, Stroke, 29, 1020, 10.1161/01.STR.29.5.1020

Barth, 2007, Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes, Diabetologia, 50, 2200, 10.1007/s00125-007-0768-z

Grant, 1998, Matrix metalloproteinase expression in human retinal microvascular cells, Diabetes, 47, 1311, 10.2337/diabetes.47.8.1311

Noda, 2003, Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 44, 2163, 10.1167/iovs.02-0662

Noda, 2005, Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells, Investig. Ophthalmol. Vis. Sci., 46, 3817, 10.1167/iovs.04-1528

Kohner, 1989, Diabetic retinopathy, Br. Med. Bull., 45, 148, 10.1093/oxfordjournals.bmb.a072309

Valentin, 2005, Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells, Fundam. Clin. Pharmacol., 19, 661, 10.1111/j.1472-8206.2005.00371.x

Yoon, 2002, Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway, J. Biol. Chem., 277, 30271, 10.1074/jbc.M202647200

Kim, 2007, Pro-MMP-2 activation by the PPARgamma agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK, FEBS Lett., 581, 3303, 10.1016/j.febslet.2007.06.012

Liu, 2008, The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview, Neurochem. Res., 33, 194, 10.1007/s11064-007-9403-0

Al-Shabrawey, 2008, Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 49, 3231, 10.1167/iovs.08-1754

Xie, 2008, Mitochondrial DNA oxidative damage triggering mitochondrial dysfunction and apoptosis in high glucose-induced HRECs, Invest. Ophthalmol. Visual Sci., 49, 4203, 10.1167/iovs.07-1364

Busik, 2008, Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators, Diabetes, 57, 1952, 10.2337/db07-1520

Fu, 2008, Activation and silencing of matrix metalloproteinases, Semin. Cell Dev. Biol., 19, 2, 10.1016/j.semcdb.2007.06.005

Worley, 2003, Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP), Biochem. J., 372, 799, 10.1042/bj20021573

Osenkowski, 2004, Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP), J. Cell. Physiol., 200, 2, 10.1002/jcp.20064

Thrailkill, 2007, Matrix metalloproteinase-2 dysregulation in type 1 diabetes, Diabetes Care, 30, 2321, 10.2337/dc07-0162

Li, 2007, The roles of MMP-2/TIMP-2 in extracellular matrix remodelling in the hearts of STZ-induced diabetic rats, Acta Cardiol., 62, 485, 10.2143/AC.62.5.2023412

Chung, 2006, Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature, Circ. Res., 99, 140, 10.1161/01.RES.0000232352.90786.fa

Liu, 2008, Cysteine-rich protein 61 and connective tissue growth factor induce de-adhesion and anoikis of retinal pericytes, Endocrinology, 149, 1666, 10.1210/en.2007-1415

Kwan, 2004, Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro, FASEB J., 18, 690, 10.1096/fj.02-1202fje

Dawson, 2004, Deadly conversations: nuclear–mitochondrial cross-talk, J. Bioenerg. Biomembr., 36, 287, 10.1023/B:JOBB.0000041755.22613.8d

PZheng, 2004, Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB, Diabetes, 53, 2960, 10.2337/diabetes.53.11.2960

Thông tin
Thông tin xuất bản

Free Radical Biology and Medicine

Tập 46

1677-1685

Thông tin tác giả